QA: Kinnate Biopharma Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001797768_2022_Kinnate_Biopharma_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001797768, Kinnate Biopharma Inc

  xvar xval
0 AssetsCurrent 258,690,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 956,000
3 remainder_Assets 107,218,000
4 LiabilitiesCurrent 12,387,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,945,000
9 ResearchAndDevelopmentExpense 67,166,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 348,000
13 remainder_ComprehensiveNetIncome -515,000
  yvar yval
0 Assets 366,864,000
1 Liabilities 12,387,000
2 Expenses 90,111,000
3 Revenues 0
4 StockholdersEquity 354,477,000
5 NetIncome -89,763,000
6 ComprehensiveNetIncome -90,020,500
7 BaseVar 235,112,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.60
9 EconomicCapitalRatio 4.10

Edgar->Model Mapping

Feature Distribution